|
RBM28 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.77089995392998E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.64580000131076E-08 |
| Normal-vs-Stage2 |
3.384700E-03 |
| Normal-vs-Stage3 |
1.53849999962041E-07 |
| Normal-vs-Stage4 |
8.72110161864725E-11 |
| Stage1-vs-Stage2 |
1.736830E-01 |
| Stage1-vs-Stage3 |
3.377200E-01 |
| Stage1-vs-Stage4 |
1.307920E-02 |
| Stage2-vs-Stage3 |
8.699900E-02 |
| Stage2-vs-Stage4 |
3.440500E-03 |
| Stage3-vs-Stage4 |
1.029410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80859999982164E-07 |
| Normal-vs-AfricanAmerican |
2.51699999997967E-06 |
| Normal-vs-Asian |
4.758500005142E-08 |
| Caucasian-vs-AfricanAmerican |
1.862370E-01 |
| Caucasian-vs-Asian |
3.988800E-01 |
| AfricanAmerican-vs-Asian |
4.778400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.05890004834464E-09 |
| Normal-vs-Female |
2.02519999659145E-08 |
| Male-vs-Female |
1.210030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.29079993757853E-10 |
| Normal-vs-Age(41-60Yrs) |
4.150500000355E-07 |
| Normal-vs-Age(61-80Yrs) |
2.02910000002277E-06 |
| Normal-vs-Age(81-100Yrs) |
1.081700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.757200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.231000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.555800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.786400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.360200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.256200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.602100E-03 |
| Classical-VS-Follicular |
4.969800E-01 |
| Classical-VS-Other |
4.381000E-01 |
| Classical-VS-Normal |
4.78910000545341E-08 |
| Tall-VS-Follicular |
3.802400E-02 |
| Tall-VS-Other |
4.811800E-01 |
| Tall-VS-Normal |
3.54579998695925E-09 |
| Follicular-VS-Other |
7.112800E-01 |
| Follicular-VS-Normal |
3.47099999997713E-06 |
| Other-VS-Normal |
5.737400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.78490002964583E-09 |
| Normal-vs-N1 |
1.02800000001402E-06 |
| N0-vs-N1 |
7.330600E-01 |
|
|
